Mallorie B. Heneghan
No Rating Available
(Learn About Our Rating System)

Mallorie B. Heneghan, MD, MS

Languages spoken: English

Dr. Heneghan is an Assistant Professor of Pediatrics at the University of Utah in the Division of Pediatric Hematology/Oncology at Primary Children´s Medical Center. Dr. Heneghan is board-certified in Pediatrics and Pediatric Hematology and Oncology.

Dr. Heneghan received her medical degree from the Perelman School of Medicine at the University of Pennsylvania, completed her Pediatric residency at the Children's Hospital of Philadelphia, and her Pediatric Hematology/Oncology Fellowship at Northwestern University/Ann and Robert H Lurie Children's Hospital of Chicago. She received additional research training earning a Master of Science in Health Services and Outcomes Research from Northwestern University Feinberg School of Medicine.

Dr. Heneghan's clinical interest include care of children, adolescents, and young adults with leukemia, lymphoma and various other cancers. Dr. Heneghan's research interests include technology-based interventions, data science, and patient-reported outcomes to predict, monitor, and improve outcomes for children, adolescents, and young adults with hematologic malignancies.

Specialties

Board Certification

American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)
American Board of Pediatrics (Pediatrics)

Dr. Heneghan is an Assistant Professor of Pediatrics at the University of Utah in the Division of Pediatric Hematology/Oncology at Primary Children´s Medical Center. Dr. Heneghan is board-certified in Pediatrics and Pediatric Hematology and Oncology.

Dr. Heneghan received her medical degree from the Perelman School of Medicine at the University of Pennsylvania, completed her Pediatric residency at the Children's Hospital of Philadelphia, and her Pediatric Hematology/Oncology Fellowship at Northwestern University/Ann and Robert H Lurie Children's Hospital of Chicago. She received additional research training earning a Master of Science in Health Services and Outcomes Research from Northwestern University Feinberg School of Medicine.

Dr. Heneghan's clinical interest include care of children, adolescents, and young adults with leukemia, lymphoma and various other cancers. Dr. Heneghan's research interests include technology-based interventions, data science, and patient-reported outcomes to predict, monitor, and improve outcomes for children, adolescents, and young adults with hematologic malignancies.

Board Certification and Academic Information

Academic Departments Pediatrics -Assistant Professor (Clinical)
Academic Divisions Hematology/Oncology
Board Certification
American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)
American Board of Pediatrics (Pediatrics)

Education history

Undergraduate Psychology - Colgate University B.A.
Certification Post-Baccalaureate Premedical Certificate - Goucher College Certification
Professional Medical Medicine - University of Pennsylvania Perelman School of Medicine M.D.
Residency Pediatrics - Children¿s Hospital of Philadelphia Resident
Fellowship Pediatrics Hematology, Oncology, and Stem Cell Transplant - Ann & Robert H. Lurie Children's Hospital, Northwestern University Feinberg School of Medicine Fellow
Graduate Training Health Services and Outcomes Research - Center for Education in Health Sciences, Northwestern University Feinberg School of Medicine M.S.
Fellowship Pediatrics Hematology, Oncology, and Stem Cell Transplant - Ann & Robert H. Lurie Children's Hospital, Northwestern University Feinberg School of Medicine Chief Fellow

Selected Publications

Journal Article

  1. Desai AV, Heneghan MB, Li Y, Bunin NJ, Grupp SA, Bagatell R, Seif AE (2016). Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma. Bone Marrow Transplant, 51(9), 1204-10.
  2. Ramsey WA, Heidelberg RE, Gilbert AM, Heneghan MB, Badawy SM, Alberts NM (2020). eHealth and mHealth interventions in pediatric cancer: A systematic review of interventions across the cancer continuum. Psychooncology, 29(1), 17-37.
  3. Badawy SM, Shah R, Beg U, Heneghan MB (2020). Habit Strength, Medication Adherence, and Habit-Based Mobile Health Interventions Across Chronic Medical Conditions: Systematic Review. J Med Internet Res, 22(4), e17883.
  4. Heneghan MB, Hussain T, Barrera L, Cai SW, Haugen M, Duff A, Shoop J, Morgan E, Rossoff J, Weinstein J, Hijiya N, Cella D, Badawy S (2020). Applying the COM-B model to patient-reported barriers to medication adherence in pediatric acute lymphoblastic leukemia. Pediatric blood & cancer, 67(5), e28216.
  5. Nagao K, Zhu J, Heneghan MB, Hanson JC, Morasso MI, Tessarollo L, Mackem S, Udey M (2009). Abnormal placental development and early embryonic lethality in EpCAM-null mice. PloS one, 4(12), e8543.
  6. Heneghan MB, Rheingold SR, Li Y, Seif AE, Huang YS, McLeod L, Wells L, Fisher BT, Aplenc (2016). Treatment of Osteonecrosis in Children and Adolescents With Acute Lymphoblastic Leukemia. Clinical lymphoma, myeloma & leukemia, 16(4), 223-229.e2.
  7. Oshrine BR, Olsen MN, Heneghan M, Wertheim G, Daber R, Wilmoth DM, Biegel JA, Pawel B, Aplenc R, King R (2014). Acquired isochromosome 12p, somatic TP53 and PTEN mutations, and a germline ATM variant in an adolescent male with concurrent acute megakaryoblastic leukemia and mediastinal germ cell tumor. Cancer genetics, 207(4), 153-9.
  8. Heneghan M, Hart J, Dewan M, Wu K, Hope K, Taylor A, Shaw K, Bamat (2018). No Cause for Alarm: Decreasing Inappropriate Pulse Oximetry Use in Bronchiolitis. Hospital pediatrics,
  9. Heneghan MB, Hussain T, Barrera L, Cai SW, Haugen M, Morgan E, Rossoff J, Weinstein J, Hijiya N, Cella D, Badawy S (2021). Access to Technology and Preferences for an mHealth Intervention to Promote Medication Adherence in Pediatric Acute Lymphoblastic Leukemia: Approach Leveraging Behavior Change Techniques. Journal of medical Internet research, 23(2), e24893.
  10. Heneghan M, Westphal K, Bergman L, Falkiner R, Filipova L, Geisler S, Kendrich C, Martinez J, Malone S, Haymond S, Callas D, MacQuarrie K (2021). Closed loop communication using provider team-specific smartphones improves the critical laboratory value notification process in paediatric inpatients. BMJ open quality, 10(3),
  11. King K, Cai S, Barrera L, Reddy P, Heneghan MB, Badawy S (2023). Barriers to medication adherence in sickle cell disease: A comprehensive theory-based evaluation using the COM-B model. Pediatric blood & cancer, e30440.
  12. Newman H, Li Y, Huang YV, Elgarten CW, Myers RM, Ruiz J, Zheng DJ, Leahy AB, Aftandilian C, Arnold SD, Bona K, Gramatges MM, Heneghan MB, Maloney KW, Modi AJ, Mody RJ, Morgan E, Rubnitz J, Winick N, Wilkes JJ, Seif AE, Fisher BT, Aplenc R, Getz K (2024). Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity research. Cancer medicine, 13(7), e6966.
  13. Heneghan MB, Parsons SK, Keller FG, Renfro LA, Pei Q, Rodday AM, Wu Y, Punnett A, Belsky JA, Henderson TO, Kelly KM, Castellino S (2024). Protocol-Stipulated Dose Modification to Manage Chemotherapy-Induced Peripheral Neuropathy in Children, Adolescents, and Young Adults With High-Risk Hodgkin Lymphoma. JCO oncology practice, OP2400089.
  14. Yang MM, Singh R, Haugen M, Duff A, Shoop J, Morgan ER, Rossoff JE, Weinstein JL, Heneghan MB, Badawy S (2025). Adherence to 6-Mercaptopurine (6-MP) and Habit Strength in Pediatric Acute Lymphoblastic Leukemia (ALL). European journal of haematology,
  15. Parker K, Heneghan MB, Li QW, Brunson A, Ou J, Kaddas HK, Abrahão R, Chubak J, Wernli KJ, Zebrack B, Hahn EE, Kushi LH, Nichols HB, Keegan T, Kirchhoff A (2025). Identifying clustering in patterns of late effects among survivors of adolescent and young adult Hodgkin lymphoma. JNCI cancer spectrum, 9(6),
  16. Dakhallah N, Steglich J, Gowdy C, Milgrom SA, Alazraki AL, Castellino SM, Dieckmann K, Flerlage JE, Heneghan MB, Kelly KM, Lai HA, Mauz-Körholz C, McCarten KM, Pabari R, Palese M, Kurch L, Stoevesandt D, Seelisch J, Voss S (2026). Imaging pitfalls in pediatric, adolescent, and young adult hodgkin lymphoma: a SEARCH for CAYAHL initiative to bridge multidisciplinary patient care. Journal of the National Cancer Institute,

Review

  1. Ansari N, Wilson CM, Heneghan MB, Supiano K, Mooney (2022). How technology can improve communication and health outcomes in patients with advanced cancer: an integrative review. Supportive care in cancer, 30(8), 6525-6543.
  2. Zeng XL, Heneghan MB, Badawy S (2023). Adherence to Oral Chemotherapy in Acute Lymphoblastic Leukemia during Maintenance Therapy in Children, Adolescents, and Young Adults: A Systematic Review. Current oncology (Toronto, Ont.), 30(1), 720-748.
  3. Werk RS, Heneghan MB, Badawy S (2024). Use of Patient-Centered Technology and Digital Interventions in Pediatric and Adult Patients with Hematologic Malignancies. Current hematologic malignancy reports,
  4. Heneghan MB, Belsky JA, Milgrom SA, Forlenza C (2024). The pediatric approach to Hodgkin lymphoma. Seminars in hematology, 61(4), 245-252.
  5. Crisler KM, Heneghan MB, Kahn J (2026). New Developments in Hodgkin's Lymphoma: Outcomes and Disparities in Classic Hodgkin Lymphoma. Hematology/oncology clinics of North America,

Other

  1. Heneghan MB, Castellino SM, Thompson L (2024). What Is Childhood Lymphoma?. JAMA pediatrics,